Longwood Fund Closes $180 Million Fund to Create and Invest in Early-Stage Biotechnology Companies May 3, 2023
Werewolf Therapeutics Publishes Preclinical Data on mWTX-330, an IL-12 INDUKINE™ Molecule, in Cancer Immunology Research April 20, 2023
Lassen Therapeutics Presents Data Demonstrating Anti-IL18 Binding Protein Antibody Efficacy and Enhancement of Anti-Tumor Immunity April 18, 2023
Axial Therapeutics Announces Age Expansion in Global Phase 2b Clinical Trial for Irritability Associated with Autism Spectrum Disorder April 6, 2023
Axial Therapeutics Announces Key R&D Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics March 30, 2023
Pyxis Oncology Reports Financial Results for the Fiscal Year Ended December 31, 2022, and Provides Corporate Update March 27, 2023
